微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-036167 Size: 10 KB 网页链接
$Exagen(XGN)$ 内部交易: 2020-05-28,Director,TULLIS JAMES L L ,卖出,848普通股, $11.93
$Exagen(XGN)$ 内部交易: 2020-05-27,Director,TULLIS JAMES L L ,卖出,1595普通股, $12.57
$Exagen(XGN)$ 内部交易: 2020-05-27,Director,TULLIS JAMES L L ,卖出,605普通股, $12.57
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-032932 Size: 11 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-031883 Size: 8 KB 网页链接
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-20-000037 Act: 34 Size: 5 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-20-000036 Act: 34 Size: 195 KB 网页链接
$Exagen(XGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001274737-20-000032 Act: 34 Size: 193 KB 网页链接
$Exagen(XGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001274737-20-000031 Act: 34 Size: 1 MB 网页链接